These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 5655580)

  • 1. Determination of phenaglycodol in biologic specimens by ultraviolet spectrophotometry.
    Wallace JE
    J Pharm Sci; 1968 Mar; 57(3):426-9. PubMed ID: 5655580
    [No Abstract]   [Full Text] [Related]  

  • 2. Placebo-controlled evaluation of phenaglycodol in anxious, depressed outpatients.
    Brauzer B; Goldstein BJ
    J Clin Pharmacol New Drugs; 1972 Jul; 12(7):280-5. PubMed ID: 4557536
    [No Abstract]   [Full Text] [Related]  

  • 3. [Possibilities of ultraviolet spectrophotometry for diagnosis of certain cases of poisoning].
    Dérobert L; Le Breton R; Garat J
    Ann Med Leg Criminol Police Sci Toxicol; 1967; 47(3):257-66. PubMed ID: 5633251
    [No Abstract]   [Full Text] [Related]  

  • 4. [Identification and urinary elimination of phenaglycodol].
    CIMA L; FASSINA G
    Farmaco Prat; 1959 Jul; 14():416-23. PubMed ID: 13849393
    [No Abstract]   [Full Text] [Related]  

  • 5. Determination of drugs in biologic specimens.
    Wallace JE; Ladd SL
    IMS Ind Med Surg; 1970 Oct; 39(10):412-9. PubMed ID: 5273428
    [No Abstract]   [Full Text] [Related]  

  • 6. [The demonstration of pharmacologic agents in cadaver organs after therapeutic dosage by various forensic toxicologic methods].
    Falzi G; Gruden N; Marozzi E
    Dtsch Z Gesamte Gerichtl Med; 1967; 61(2):81-94. PubMed ID: 4386097
    [No Abstract]   [Full Text] [Related]  

  • 7. Phenaglycodol therapy in cerebral palsy.
    KUGELMASS IN
    Ann N Y Acad Sci; 1958 Oct; 72(8):271-92. PubMed ID: 13583888
    [No Abstract]   [Full Text] [Related]  

  • 8. Phenaglycodol: a new antiepileptic agent.
    GRUBER CM; MOSIER JM
    Proc Soc Exp Biol Med; 1957 Feb; 94(2):384-5. PubMed ID: 13408268
    [No Abstract]   [Full Text] [Related]  

  • 9. Mode of action of phenaglycodol, a new neurosedative agent.
    JONES GT; SLATER IH; YOUNG WK
    Proc Soc Exp Biol Med; 1956 Dec; 93(3):528-31. PubMed ID: 13389510
    [No Abstract]   [Full Text] [Related]  

  • 10. Tolerance and withdrawal hyperexcitability induced in mice by chronic administration of phenaglycodol.
    CHIN L; SWINYARD EA
    Proc Soc Exp Biol Med; 1958 Jan; 97(1):251-4. PubMed ID: 13518240
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparative effects of phenaglycodol and meprobamate on anxiety reactions.
    ZUKIN P; ARNOLD DG; KESSLER CR
    J Nerv Ment Dis; 1959 Aug; 129():193-5. PubMed ID: 13847900
    [No Abstract]   [Full Text] [Related]  

  • 12. [Early results of the use of 2-p-chlorophenyl-3-methyl-2,3-butanediol (phenaglycodol) in neuropsychiatric therapy].
    IMBERCIADORI E
    Minerva Med; 1960 Mar; 51():757-60. PubMed ID: 13852743
    [No Abstract]   [Full Text] [Related]  

  • 13. Pentylenetetrazol seizure threshold in meprobamate- and phenaglycodol-treated mice.
    CHIN L; SWINYARD EA
    J Am Pharm Assoc Am Pharm Assoc; 1959 Jan; 48(1):6-8. PubMed ID: 13610718
    [No Abstract]   [Full Text] [Related]  

  • 14. [Spectrophotometric studies on therapeutic drugs from the phenothiazine derivative group in the ultraviolet range of the spectrum].
    Blazek J; Krácmar J; Pinkasová M
    Agressologie; 1968; 9(1):69-75. PubMed ID: 5681823
    [No Abstract]   [Full Text] [Related]  

  • 15. A comparison of phenaglycodol (ultran), meprobamate and a placebo in abstinent alcoholics.
    SMITH JA; RUTHERFORD A; FANNING R
    Am J Psychiatry; 1957 Oct; 114(4):364-5. PubMed ID: 13458502
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparative effect of phenaglycodol, meprobamate, and a placebo on the irritable colon; a double-blind study.
    KASICH AM; FEIN HD; MILLER JW
    Am J Dig Dis; 1959 Mar; 4(3):229-34. PubMed ID: 13626924
    [No Abstract]   [Full Text] [Related]  

  • 17. An analysis of the analgesic effect of dextropro-poxyphene hydrochloride, phenaglycodol, and aspirin combination (darvo-tran).
    SETTEL E
    Antibiotic Med Clin Ther (New York); 1959 Sep; 6():512-7. PubMed ID: 14445201
    [No Abstract]   [Full Text] [Related]  

  • 18. Quantitative determination of butaperazine by TLC.
    Kapadia AJ; Barber MA; Martin AE
    J Pharm Sci; 1970 Oct; 59(10):1476-9. PubMed ID: 4394317
    [No Abstract]   [Full Text] [Related]  

  • 19. [Determination of phenaglycodol].
    CERRI O
    Boll Chim Farm; 1958 May; 97(5):261-2. PubMed ID: 13560622
    [No Abstract]   [Full Text] [Related]  

  • 20. [Thin layer chromatography without binding agent in drug analysis. 8. Separation and quantitative determination of antihistaminics and ataraxics].
    Sarsúnová M; Kakác B; Schwarz V; Malý V; Protiva J
    Pharmazie; 1966 Dec; 21(12):752-5. PubMed ID: 4386457
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.